MARKET EYE-SGX Nifty gains; pharma stocks in focus

Fri Nov 23, 2012 9:03am IST

Related Topics

Stocks

   

* Nifty futures on the Singapore Exchange rise 0.21
percent. The MSCI-Asia Pacific index excluding Japan
 is also up 0.4 percent. 
* Asian shares ambled higher on Friday and were on course for a
weekly gain of more than 2 percent, their best in two months,
after manufacturing surveys from China and the United States
raised hopes that the global growth outlook is improving at
last. 
* Foreign investors bought 1.83 billion rupees, while Domestic
institutions sold 1.64 billion rupees of stocks on Thursday when
the BSE index rose 0.31 percent.
* Pharmaceutical shares will be in focus, as India approved a
new drug pricing policy designed to increase the number of drugs
deemed essential that are subject to price caps, two ministers
told reporters. 
* India's cabinet approved on Thursday a 9.5 percent government
stake sale in state-run power producer NTPC Ltd, a
minister told reporters, to help rein in its ballooning fiscal
deficit. 
* Investors will watch Hindustan Copper Ltd shares a
day after it sets floor price for share sale at 155 rupees a
share. Hindustan Copper shares closed at 266.15 rupees on
Thursday. 

 (manoj.dharra@thomsonreuters.com)
FILED UNDER:

Reuters Showcase

FMC-SEBI Merger

FMC-SEBI Merger

Regulatory shakeup could revive commodities markets   Full Article 

Market Eye

Market Eye

Sensex, Nifty end higher after bumpy budget-day trading  Full Article 

Tax Incentives

Tax Incentives

Budget woos foreign investors  Full Article 

Excise Duty

Excise Duty

Cigarette makers fall after budget hikes excise duty  Full Article 

Welcoming the Budget

Welcoming the Budget

India Inc cheers corporate tax cut, simpler rules  Full Article 

Gold Price

Gold Price

Gold prices to rise after budget keeps import duty high  Full Article 

Fuel Prices

Fuel Prices

IOC to raise diesel, petrol prices from Sunday  Full Article 

Moody's on Budget

Moody's on Budget

Budget "credit neutral" from a ratings perspective - Moody's   Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage